The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis
Authors:
- 25 December 2010
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 128 (1) , 203-209
Abstract
Thymidylate synthase (TYMS), which catalyzes the conversion of deoxyuridine monophosphate to deoxythymidine monophosphate, is a central enzyme in the folate metabolic pathway. Epidemiological studies have evaluated the association between TYMS gene polymorphisms and breast cancer susceptibility; however, the published data are still inconclusive. To derive a more precise assessment of this relationship, we performed a meta-analysis based on currently available data by searching PubMed, EMBASE databases, and the Cochrane Library. A total of 10 eligible studies were identified for the TYMS TSER polymorphism (six studies with 2,718 cases and 3,423 controls) and for the TYMS TS3′-UTR polymorphism (five studies with 1,969 cases and 2,290 controls). The overall odds ratio (OR) and the corresponding 95% confidence interval (CI) showed a statistical association between the TSER polymorphism and breast cancer risk under homozygote comparison (2R/2R vs. non-2R/non-2R; OR 1.25; 95% CI 1.04–1.50), allele contrast (2R vs. non-2R; OR 1.09; 95% CI 1.01–1.19) and the recessive model (OR 1.19; 95% CI 1.01–1.39). In the subgroup analysis by ethnicity, a statistically significant increase in cancer risk was found among Caucasians for homozygote comparison (OR 1.31; 95% CI 1.10–1.57), the allele contrast model (OR 1.12; 95% CI 1.02–1.23) and the dominant model (OR 1.40; 95% CI 1.00–1.95). For the TS3′-UTR polymorphism, significant effects were shown using the allele contrast model (OR 1.33; 95% CI 1.03–1.73). However, the TS3′-UTR polymorphism increased breast cancer risk among Asian women (del6 vs. ins6; OR 1.41; 95% CI 1.01–1.98) but not Caucasian women using the homozygote comparison. In conclusion, our meta-analysis suggests that the TSER polymorphism may increase susceptibility to breast cancer in the Caucasian population and the TS3′-UTR polymorphism may be a genetic determinant for developing breast cancer in the Asian population; therefore, ethnic background should be carefully considered in further studies.Keywords
This publication has 27 references indexed in Scilit:
- Genetic susceptibility to breast cancerMolecular Oncology, 2010
- One-Carbon Metabolism–Genome Interactions in Folate-Associated Pathologies ,The Journal of Nutrition, 2009
- Dietary Intake of Folate, Vitamin B2, Vitamin B6, Vitamin B12, Genetic Polymorphism of Related Enzymes, and Risk of Breast Cancer: A Case-Control Study in JapanNutrition and Cancer, 2009
- Folate and Risk of Breast Cancer: A Meta-analysisJNCI: Journal of the National Cancer Institute, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Plasma Folate, Vitamin B6, Vitamin B12, Homocysteine, and Risk of Breast CancerJNCI: Journal of the National Cancer Institute, 2003
- Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancerInternational Journal of Oncology, 2001
- Dietary Folate Consumption and Breast Cancer RiskJNCI: Journal of the National Cancer Institute, 2000
- Folate and carcinogenesis: evidence, mechanisms, and implicationsThe Journal of Nutritional Biochemistry, 1999